SCHEMBL14348136

SCHEMBL14348136

CCCCS(=O)(=O)C[C@@H](NC(=O)n1cc(C)cn1)C(=O)N[C@@H](Cc1cc(F)cc(F)c1)[C@H](O)CNCc1cccc(C(F)(F)F)c1

nearest known ligand 0.65

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CTSB P07858 20/20 0.65
BACE1 P56817 20/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14348133 0.89 CTSB (0.62) CTSBBACE1
SCHEMBL14348140 0.87 BACE1 (0.50) CTSBBACE1
SCHEMBL4666312 0.85 CTSB (0.74) CTSBBACE1
SCHEMBL4668118 0.85 CTSB (0.86) CTSBBACE1
SCHEMBL5579460 0.84 BACE1 (0.48) CTSBBACE1
SCHEMBL14348119 0.83 CTSB (0.74) CTSBBACE1
SCHEMBL14348135 0.82 BACE1 (0.56) CTSBBACE1
SCHEMBL4666353 0.82 BACE1 (0.68) CTSBBACE1
SCHEMBL14347858 0.80 CTSB (0.84) CTSBBACE1
SCHEMBL14131563 0.80 CTSB (0.41) CTSBBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299263-A1 Hydroxy Alkyl Amines Elan Pharmaceuticals, Inc. and Pharmacia & Upjohn Company 2007-12-27 US disclosed
US-20070299263-A1 Hydroxy Alkyl Amines Elan Pharmaceuticals, Inc. and Pharmacia & Upjohn Company 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299263-A1 Hydroxy Alkyl Amines MAOA, PSEN2, PSEN1 CTSB 2593/4885BACE1 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.